New Products: ADX's Alzheimer's Assays | GenomeWeb

ADX has released its new set of diagnostic assays for Alzheimer's disease, comprising ELISAs for β-amyloid 1-40 and 1-42 and total tau.

Offered through the company's partner Euroimmun, the assays are EU CE marked, automatable, and do not suffer from matrix effects, the company said.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.